Use of combined inhalers for stable chronic obstructive pulmonary disease
Amanda Wilson @MediaDoctorAU Senior lecturer, School of Nursing and Midwifery, University of Newcastle, New South Wales, Australia, Cochrane Nursing Care Field
The mission of the Cochrane Nursing Care Field (CNCF) is to improve health outcomes through increasing the use of the Cochrane Library and supporting Cochrane’s role by providing an evidence base for nurses and healthcare professionals who deliver, lead or research nursing care. The CNCF produces Cochrane Corner columns, summaries of recent nursing-care-relevant Cochrane Reviews that are regularly published in collaborating nursing-related journals. Information on the processes CNCF has developed can be accessed at: cncf.cochrane.org/evidence-transfer-program-review-summaries. This is a Cochrane review summary of: Horita N, Goto A, Shibata Y et al (2017) Long-acting muscarinic antagonist (LAMA) plus long-acting beta-agonist (LABA) versus LABA plus inhaled corticosteroid (ICS) for stable chronic obstructive pulmonary disease (COPD). Cochrane Database of Systematic Reviews. Issue 2. CD012066. doi: 10.1002/14651858. CD012066.pub2.
32, 25, 47-48.
Conflict of interest
This Cochrane Corner article is available at: rcni.com/Cochranecorner
For related articles search the website using the keywords
Received: 29 January 2018
Accepted: 29 January 2018
Published online: 13 February 2018
Want to read more?
Subscribe for unlimited access
Try 1 month’s access for just £1 and get:
Your subscription package includes:
- Full access to nursingstandard.com and the Nursing Standard app
- The monthly digital edition
- RCNi Portfolio and interactive CPD quizzes
- RCNi Learning with 200+ evidence-based modules
- 10 articles a month from any other RCNi journal
Already subscribed? Log in
Alternatively, you can purchase access to this article for the next seven days. Buy now